SARS-CoV-2 NSP8 Polyclonal Antibody(2019-nCoV)

Dodavatel: Reddot Biotech USA Inc.
Teplota skladování: Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Katalogové číslo:
RD90437A/50
50μL
9 660,00 Kč
NA OBJEDNÁNÍ
RD90437A/100
100μL
16 036,00 Kč
NA OBJEDNÁNÍ
Velikost balení:
Cena bez DPH:
Dostupnost:
Vložit do košíku
Zobrazovat ceny: bez DPH / včetně DPH
This is a SARS-CoV-2 NSP8 (2019-nCoV) Virus Antibody from Reddot Biotech. This product is for Research Use Only.
Cleavage by the viral main protease, 3CLpro results in generating the nsp8 protein, The nsp8 protein has been shown to associate with several other nsps and to colocalize with these nsps in cytoplasmic complexes that are important for viral RNA synthesis. It forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, may synthesize substantially longer products than oligonucleotide primers. Nsp8 was shown to have RNA-dependent RNA polymerase (RdRp) activity that could be involved in producing primers utilized by nsp12 which is normally accepted to be the RdRp for SARS-CoV.
ClonalityPolyclonal
Purification MethodProduced in rabbits immunized with purified,Recombinant SARS-CoV-2 NSP8
IsotypeIgG
HostRabbit
ImmunogenRecombinant SARS-CoV-2 NSP8
ReactivitySARS-COV2
ApplicationsELISA
ConjugationUnconjugated
DilutionELISA 1:4000-1:8000
Concentration0.93mg/mL
BufferPBS, pH7.4, containing 0.05% proclin300, 50% glycerol.
0
RD90437A/100